Anthony Linton

Learn More
In three experiments a solution of formic acid (Bioadd) was added to feed 'naturally' contaminated with salmonellas. In two of them no salmonella infections were demonstrated in broiler chickens given feed containing 0.6 per cent (w/w) of the formic acid solution for seven weeks and in the third the infection rate was reduced considerably. In four other(More)
AIMS The accurate diagnosis of malignant pleural mesothelioma (MPM) is essential for therapeutic and legal reasons. In 2006 the International Mesothelioma Panel advocated the use of a panel, including two mesothelial and two non-mesothelial immunohistochemical (IHC) markers. We assessed the changing use of IHC for the diagnosis of MPM in Australia over two(More)
Malignant pleural mesothelioma (MPM) is an asbestos-induced cancer with poor prognosis that displays characteristic alterations in microRNA expression. Recently it was reported that the expression of a subset of microRNAs can distinguish between MPM and adenocarcinoma of the lung. However, the functional importance of these changes has yet to be(More)
BACKGROUND The modified Glasgow Prognostic Score (mGPS), derived from C-reactive protein (CRP) and albumin levels, and the neutrophil-lymphocyte ratio (NLR) have demonstrated prognostic significance in a number of malignancies. PATIENTS AND METHODS Baseline mGPS and NLR were calculated in a prospective cohort of chemotherapy-naive patients with metastatic(More)
BACKGROUND Prognosis of malignant pleural mesothelioma (MPM) is poor, and predicting the outcomes of treatment is difficult. Here we investigate the potential of microRNA expression to estimate prognosis of MPM patients. METHODS Candidate microRNAs from microarray profiling of tumor samples from 8 long (median: 53.7 months) and 8 short (median: 6.4(More)